Rapcabtagene Autoleucel -YTB323 rapidly manufactured CD19 CAR T #POS0303 #EULAR2026 @RheumNow 24 months follow up data for 21 pts. Durable b cell reduction and decrease in disease activity. https://t.co/m3lYjZJJIy